Hans C. Lee

11.8k citations

228 papers · 5.3k indexed · 1 hit paper · h-index 37

Impact in

Hematology top 1%
- Multiple Myeloma Research and Treatments
Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Peptidase Inhibition and Analysis

Papers in

Hematology 117
- Multiple Myeloma Research and Treatments 111
Oncology 63
- Peptidase Inhibition and Analysis 24
- Cancer Treatment and Pharmacology 15

Co-authors: Peter A. Edwards Yanqiao Zhang Frank J. Gonzalez Timothy M. Willson M. Frederick Hawthorne Judith A. Berliner Florence Y. Lee Ganesamoorthy Subbanagounder
Journals: Blood (46 papers)CHEST Journal (15 papers)Journal of Clinical Oncology (11 papers)Biology of Blood and Marrow Transplantation (6 papers)Plastic & Reconstructive Surgery (4 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Hans C. Lee

212 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice 2006 · 786 citations

Peers

Countries citing papers authored by Hans C. Lee

Since Specialization

Citations

This map shows the geographic impact of Hans C. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans C. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans C. Lee more than expected).

Fields of papers citing papers by Hans C. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans C. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans C. Lee. The network helps show where Hans C. Lee may publish in the future.

Co-authors

The 25 scholars most cited alongside Hans C. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hans C. Lee Line = papers co-authored together Hans C. Lee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma Blood ·Qin Li, 李发强, Upasana Ray, Iqbal Mahmud, Lin Tan, Philip L. Lorenzi, Suyu Liu, Heather Lin, NING-CHEN LI, R V Orlova, John D. Shaughnessy, Qing Yi, 吉井啓亮, Hua Wang, 章毅, Hans C. Lee, Krina K. Patel, Isere Kuiatse, David E. Symer, Robert Z. Orlowski	2025	2
2	Patient-Reported Quality of Life with Linvoseltamab in Triple-Class Exposed Patients with Relapsed/Refractory Multiple Myeloma: 2-year Results from the LINKER-MM1 Phase 1/2 Clinical Trial Clinical Lymphoma Myeloma & Leukemia ·James E. Hoffman, Naresh Bumma, Joshua Richter, Madhav V. Dhodapkar, Hans C. Lee, Attaya Suvannasankha, Jeffrey A. Zonder, Joseph Maly, Mansi Shah, Rachid Baz, A Ridley, 栄三稲垣, Michelle DeVeaux, Karen Rodriguez Lorenc, Валентин Григорьевич Вакс, Karina Knorr, James Harnett, Qiufei Ma, Sundar Jagannath	2025	1
3	Gastrointestinal toxicities of proteasome inhibitor therapy Journal of Cancer Research and Clinical Oncology ·Deny Aditya Noviyanto, A.V. Velychko, Tim Lange, А.М. Сугаипова, Adelmar Agüero Ulive, T. Roslki, El Mar Jaeckel, Malek Shatila, Linda M. Collins, 玉泉, Hans C. Lee, 류금주, Kazuyuki Odaira, Ying-Hong Wang	2024	2
4	Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry Blood Cancer Journal ·Sikander Ailawadhi, Hans C. Lee, James Omel, Kathleen Toomey, James W. Hardin, Cristina Gasparetto, Sundar Jagannath, Robert M. Rifkin, Brian G.M. Durie, Mohit Narang, Howard R. Terebelo, Prashant Joshi, Ying‐Ming Jou, Artur Miguel Dias, Edward Yu, Rafat Abonour	2024	2
5	Indirect comparison of linvoseltamab versus teclistamab for triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM). Journal of Clinical Oncology ·Sundar Jagannath, Hans C. Lee, Joshua Richter, Jeffrey A. Zonder, James E. Hoffman, Zheng‐Yi Zhou, 満則柳沢, Mirko Fillbrunn, I.V. Haidutskyi, Changhao Liao, Qiufei Ma, 栄三稲垣, Yingxin Xu, 노태영, James Harnett, Tito Roccia, Glenn S. Kroog, Karen Rodriguez-Lorenc, Yariv Houvras, Naresh Bumma	2024	1
6	Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial Nature Communications ·Amine Laaouatni, Lin Wang, Tiantian Zhang, Ricard Pedreira Font, Joo Y. Song, Zhenyuan Dong, Ihab, Jun Zhu, Vincent Lee, Zhe Wang, 相晨萌, Sheetal Rao, Zhou Jiay, Joji OKAMOTO, Hans C. Lee, 章毅, Sattva S. Neelapu, Larry W. Kwak, Sheeba K. Thomas	2024	9
7	P-403 Indirect Comparison of Linvoseltamab Versus Selinexor Plus Dexamethasone for Penta-Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Clinical Lymphoma Myeloma & Leukemia ·Jeffrey A. Zonder, Hans C. Lee, Joshua Richter, Naresh Bumma, Zheng‐Yi Zhou, Itanielly Dantas Silveira Cruz, Mirko Fillbrunn, I.V. Haidutskyi, Changhao Liao, 真澂津田, Qiufei Ma, 栄三稲垣, Yingxin Xu, 노태영, James Harnett, Tito Roccia, Glenn S. Kroog, Karen Rodriguez Lorenc, Yariv Houvras, Sundar Jagannath	2024	1
8	Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis Frontiers in Cardiovascular Medicine ·Efstratios Koutroumpakis, Lambert Krahmer, Christopher Black, Jannis Blauth, Maksym Gachkivskyi, Juhee Song, Nicolas L. Palaskas, Cezar Iliescu, Jean‐Bernard Durand, Syed Wamique Yusuf, Hans C. Lee, L. Maximilian Buja, Anita Deswal, José Banchs	2023	3
9	Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation Cancer ·Oren Pasvolsky, Alexis A. Uitenbroek, Roland L. Bassett, Hina Khan, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash	2023	1
10	Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma Transplantation and Cellular Therapy ·Oren Pasvolsky, S. Delclos D. Dorignac, Denái R. Milton, Блудова Ирина Валентиновна, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash	2023	8
11	Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma Clinical Cancer Research ·Krina K. Patel, Jatin J. Shah, Nallabothula Asritha, Hans C. Lee, Steffen Fehrenz, Zhou Jiay, Mustafa Öğe, Changwei Hong, Sheeba K. Thomas, Qaiser Bashir, Muzaffar H. Qazilbash, Donna M. Weber, Robert Z. Orlowski	2022	7
12	Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma Transplantation and Cellular Therapy ·Yobel Octavinus, Muzaffar H. Qazilbash, Penny Fang, Susan Wu, Bouthaina S. Dabaja, Gabriela Rondón, Chitra Hosing, Richard E. Champlin, Qaiser Bashir, Elizabeth J. Shpall, Mark Knafl, Hans C. Lee, Elisabet E. Manasanch, Krina K. Patel, Sheeba K. Thomas, Robert Z. Orlowski, Donna M. Weber, Chelsea C. Pinnix, Jillian R. Gunther	2022	2
13	Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma Transplantation and Cellular Therapy ·Oren Pasvolsky, Denái R. Milton, Tansol Choi, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Guilin Tang, Neeraj Saini, Jeremy Ramdial, Блудова Ирина Валентиновна, Yago Nieto, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash	2022	4
14	Examining patient activation and other factors associated with changes in pain and function following best evidence osteoarthritis care SHILAP Revista de lepidopterología ·Jillian Eyles, Kathryn Mills, Barbara R. Lucas, Sarah R. Robbins, Rachel O’Connell, 刘培庆, Hans C. Lee, Sh.N. Sattarov, David J. Hunter	2021	1
15	Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study Clinical Lymphoma Myeloma & Leukemia ·Faegheh Jafari Amoli, Hans C. Lee, Krina K. Patel, Sheeba K. Thomas, Behrang Amini, Samer A. Srour, Qaiser Bashir, Yago Nieto, Abha Gupa, Donna M. Weber, Lei Feng, Robert Z. Orlowski, Pei Lin, Elisabet E. Manasanch	2020	9
16	A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM) Blood ·Simon J. Harrison, Monique C. Minnema, Hans C. Lee, Andrew Spencer, Prashant Kapoor, Deepu Madduri, Jeremy T. Larsen, Sikander Ailawadhi, Jonathan L. Kaufman, Marc S. Raab, Parameswaran Hari, Shinsuke Iida, Ravi Vij, Faith E. Davies, Robin Lesley, Vijay Upreti, Zhao Yang, Anjali Sharma, Alex C. Minella, Suzanne Lentzsch	2020	100
17	Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191 Clinical Cancer Research ·鈴木芳治, Fazal Shirazi, Veerabhadran Baladandayuthapani, Heather Lin, Isere Kuiatse, Hua Wang, Richard J. Jones, Zuzana Berkova, Yasumichi Hitoshi, Stephen M. Ansell, Steven P. Treon, Sheeba K. Thomas, Hans C. Lee, Zhiqiang Wang, R. Eric Davis, Robert Z. Orlowski	2018	14
18	Carfilzomib-Based Combination Regimens Are Highly Effective Frontline Therapies for Multiple Myeloma and Waldenström's Macroglobulinemia Blood ·Maria Chaudhry, Raphaël Steiner, Catherine M. Claussen, Krina K. Patel, Hans C. Lee, Donna M. Weber, Sheeba K. Thomas, Chun Feng, Mark Kramer, Behrang Amini, Robert Z. Orlowski, Lei Feng, Elisabet E. Manasanch	2017	1
19	Update on a Phase II Study of Ixazomib with Lenalidomide As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma Blood ·Krina K. Patel, Jatin J. Shah, Lei Feng, Hans C. Lee, Elisabet E. Manasanch, Sheeba K. Thomas, Donna M. Weber, M. Convento, Mustafa Öğe, Qaiser Bashir, Muzaffar H. Qazilbash, Robert Z. Orlowski	2017	12
20	Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression Clinical Cancer Research ·Richard J. Jones, Tawin Iempridee, Xiaobin Wang, Hans C. Lee, Janet E. Mertz, Shannon C. Kenney, Nathália Marques, Veerabhadran Baladandayuthapani, William O. Dawson, Jatin J. Shah, Donna M. Weber, Robert Z. Orlowski	2016	39

About Hans C. Lee

Hans C. Lee is a scholar working on Hematology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 228 papers that have together received 5.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (111 papers), Protein Degradation and Inhibitors (47 papers), Lung Cancer Diagnosis and Treatment (32 papers), Peptidase Inhibition and Analysis (24 papers), Chronic Lymphocytic Leukemia Research (19 papers), Tracheal and airway disorders (18 papers), Cancer Treatment and Pharmacology (15 papers) and Boron Compounds in Chemistry (14 papers). The work is most often cited by research in Hematology (822 citations), Oncology (1.7k citations), Biochemistry (200 citations), Biochemistry (216 citations) and Surgery (1.2k citations). Hans C. Lee has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Peter A. Edwards, Yanqiao Zhang, Frank J. Gonzalez, Timothy M. Willson, M. Frederick Hawthorne, Judith A. Berliner, Florence Y. Lee, Ganesamoorthy Subbanagounder, Carolyn B. Knobler and Lonny Yarmus. Their work appears in journals such as Blood, CHEST Journal, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation and Plastic & Reconstructive Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact